International audienceThe reversible addition-fragmentation chain transfer (RAFT) polymerization of acrylic acid (AA) in water was studied in detail at different pHs using 4-cyano-4-thiothiopropylsulfanyl pentanoic add (CTPPA) as a control agent and 4,4'-azobis(4-cyanopentanoic acid) (ACPA) as an initiator. Well-defined hydrophilic macromolecular RAFT agents (PAA-CTPPA) were obtained and further used directly in water for the polymerization of styrene. The corresponding polymerization-induced self-assembly (PISA) process was evaluated at different pHs and it was shown that working in acidic conditions (pH = 2.5) led to well-defined amphiphilic block copolymer particles (D < 1.4) of small size (below 50 nm). When the pH increased, the control over the growth of the polystyrene (PS) block was gradually lost. Chain extension experiments of PAA-CTPPA with N-acryloylmorpholine (NAM), a hydrosoluble and non-pH sensitive monomer, performed at different pHs showed that the very first addition-fragmentation steps that occurred in water were impeded when PAA was ionized leading to partial consumption of PAA-CTPPA and thus to PS molar masses higher than expected. Varying the PAA-CTPPA concentration at pH = 2.5 led in all cases to stable particles composed of well-defined block copolymers with PS segments of different molar masses

n-Heptyl α-d-mannose (HM) is a nanomolar antagonist of FimH, a virulence factor of E. coli. Herein we report on the construction of multivalent HM-based glycopolymers as potent antiadhesives of type 1 piliated E. coli. We investigate glycopolymer/FimH and glycopolymer/bacteria interactions and show that HM-based glycopolymers efficiently inhibit bacterial adhesion and disrupt established cell-bacteria interactions in vitro at very low concentration (0.1 μM on a mannose unit basis). On a valency-corrected basis, HM-based glycopolymers are, respectively, 10(2) and 10(6) times more potent than HM and d-mannose for their capacity to disrupt the binding of adherent-invasive E. coli to T84 intestinal epithelial cells. Finally, we demonstrate that the antiadhesive capacities of HM-based glycopolymers are preserved ex vivo in the colonic loop of a transgenic mouse model of Crohn's disease. All together, these results underline the promising scope of HM-based macromolecular ligands for the antiadhesive treatment of E. coli induced inflammatory bowel diseases.